FundedIQ
Biotechnology

FluoSphera: Funding, Investors & Team (Sep 2026)

FluoSphera facilitates the development of effective medication with lesser unfavorable consequences as well as minimizing the need for animal testing, empowering businesses to tackle the intricacy of human physiological reactions and efficiently guard communities from harmful substances.

fluosphera.com LinkedIn Geneva, Switzerland 1-10 employees
Biotechnology Life Science Pharmaceutical B2B
Total raised
$1.0M
Rounds
1
Latest
Pre-Seed
Mar 2023

FluoSphera has raised $1.0M across 1 funding round on record, the most recent a Pre-Seed of $1.0M announced in Mar 2023.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

FluoSphera Company Profile and Key Stats

Total funding raised
$1.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Pre-Seed
$1.0M in Mar 2023
Employees
1-10
reported band
Headquarters
Geneva, Switzerland

Latest funding round on record: Mar 2023.

FluoSphera Funding Rounds

Date
Round
Amount
Pre-Seed
$1.0M

FluoSphera Founders and Leadership Team

Name
Role
Contact
Clelia Bourgoint
Founder
Locked

Contact details for the FluoSphera team: 1 of 1 has an email address on file.

Start 14-day free trial →

FluoSphera Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
879
$3.8M
5,801
$600K

FluoSphera's latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like FluoSphera in Biotechnology and Geneva

Companies Similar to FluoSphera

Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…

Series A $40.0M

At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…

Pre-Seed $3.0M

compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…

Undisclosed round $1.2M

MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…

Undisclosed round $200M

Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…

Undisclosed round $490k

Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…

Pre-Seed $120k

Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…

Undisclosed round $1.1M

AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…

Undisclosed round $4.0M

AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…

Undisclosed round $1.2M

Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…

Undisclosed round $1.4M

MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…

Undisclosed round $10.2M

Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…

Seed $7.5M

FluoSphera Funding FAQs

What does FluoSphera do?

FluoSphera facilitates the development of effective medication with lesser unfavorable consequences as well as minimizing the need for animal testing, empowering businesses to tackle the intricacy of human physiological reactions and efficiently guard communities from harmful substances.

How much funding has FluoSphera raised?

FluoSphera has raised $1.0M across 1 round on record. The most recent is a Pre-Seed of $1.0M announced in Mar 2023.

When did FluoSphera last raise funding?

FluoSphera's most recent funding round on record is a Pre-Seed of $1.0M, announced in Mar 2023.

Who founded FluoSphera?

FundedIQ lists Clelia Bourgoint (Founder) at FluoSphera.

Where is FluoSphera headquartered?

FluoSphera is based in Geneva, Geneve, Switzerland.

How many employees does FluoSphera have?

FluoSphera is in the 1-10 employee band.

How does FluoSphera's funding compare to other Biotechnology startups?

FluoSphera's latest round of $1.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's FluoSphera Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for FluoSphera is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.